Bolt Biotherapeutics Management
Management criteria checks 1/4
Bolt Biotherapeutics' CEO is Willie Quinn, appointed in May 2020, has a tenure of 4.5 years. total yearly compensation is $912.18K, comprised of 48.4% salary and 51.6% bonuses, including company stock and options. directly owns 0.095% of the company’s shares, worth $20.99K. The average tenure of the management team and the board of directors is 0.5 years and 2.9 years respectively.
Key information
Willie Quinn
Chief executive officer
US$912.2k
Total compensation
| CEO salary percentage | 48.4% |
| CEO tenure | 4.5yrs |
| CEO ownership | 0.09% |
| Management average tenure | less than a year |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Little Excitement Around Bolt Biotherapeutics, Inc.'s (NASDAQ:BOLT) Revenues As Shares Take 29% Pounding
May 21
We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully
Mar 15Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
May 13Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
Dec 01Bolt Biotherapeutics: A Promised Follow Up
Aug 26Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M
Aug 10We're Keeping An Eye On Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Jul 27We're Not Very Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Rate
Apr 12We Think Bolt Biotherapeutics (NASDAQ:BOLT) Can Afford To Drive Business Growth
Dec 03Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies
Aug 18We're Hopeful That Bolt Biotherapeutics (NASDAQ:BOLT) Will Use Its Cash Wisely
Aug 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$65m |
| Jun 30 2024 | n/a | n/a | -US$66m |
| Mar 31 2024 | n/a | n/a | -US$63m |
| Dec 31 2023 | US$912k | US$442k | -US$69m |
| Sep 30 2023 | n/a | n/a | -US$71m |
| Jun 30 2023 | n/a | n/a | -US$77m |
| Mar 31 2023 | n/a | n/a | -US$81m |
| Dec 31 2022 | US$1m | US$423k | -US$88m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$97m |
| Mar 31 2022 | n/a | n/a | -US$98m |
| Dec 31 2021 | US$2m | US$395k | -US$99m |
| Sep 30 2021 | n/a | n/a | -US$102m |
| Jun 30 2021 | n/a | n/a | -US$89m |
| Mar 31 2021 | n/a | n/a | -US$77m |
| Dec 31 2020 | US$1m | US$239k | -US$61m |
Compensation vs Market: Willie's total compensation ($USD912.18K) is above average for companies of similar size in the US market ($USD649.07K).
Compensation vs Earnings: Willie's compensation has been consistent with company performance over the past year.
CEO
Willie Quinn (53 yo)
4.5yrs
Tenure
US$912,175
Compensation
Mr. William P. Quinn, also known as Willie, is CEO, President & Director of Bolt Biotherapeutics, Inc. from May 15, 2024. He has been Chief Financial Officer at Bolt Biotherapeutics, Inc. since May 2020 an...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 4.5yrs | US$912.18k | 0.095% $ 21.0k | |
| Chief Operating Officer | less than a year | US$839.50k | 0.023% $ 5.2k | |
| VP of Finance & Principal Accounting Officer | less than a year | no data | 0.030% $ 6.6k | |
| VP & Head of Human Resources | 3.5yrs | no data | no data | |
| Senior Vice President of Pharmaceutical Operations | 2.4yrs | no data | no data | |
| Senior Vice President of Clinical Development | less than a year | no data | no data | |
| Senior Vice President of Research | less than a year | no data | no data |
0.5yrs
Average Tenure
53yo
Average Age
Experienced Management: BOLT's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | less than a year | US$912.18k | 0.095% $ 21.0k | |
| Independent Director | 3.9yrs | US$80.59k | 0.0031% $ 695.2 | |
| Independent Director | 8.2yrs | US$77.09k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$75.59k | 0% $ 0 | |
| Independent Chairman | 3yrs | US$83.09k | 0% $ 0 | |
| Director | less than a year | no data | no data | |
| Independent Director | 1.9yrs | US$65.59k | 0% $ 0 |
2.9yrs
Average Tenure
59yo
Average Age
Experienced Board: BOLT's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.